"Difficult to remove" uremic toxins

Seminars in Dialysis

Volumn 21, Issue 5, 2008, Pages 407-409

  Vanholder, Raymond ^a   Eloot, Sunny ^a   Van Biesen, Wim ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEMODIALYSIS FLUID; UREA;

ALGORITHM; ARTICLE; CHRONIC KIDNEY FAILURE; HUMAN; KIDNEY FUNCTION TEST; METABOLISM; METHODOLOGY; RENAL REPLACEMENT THERAPY; REPRODUCIBILITY;

ALGORITHMS; HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; UREA;

EID: 54749149140     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2008.00486.x     Document Type: Article

References (28)

1. Lowrie EG, Lew NL : Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15 : 458 482, 1990
2. Shinzato T, Nakai S, Akiba T, Yamazaki C, Sasaki R, Kitaoka T, Kubo K, Shinoda T, Kurokawa K, Marumo F, Sato T, Maeda K : Survival in long-term haemodialysis patients: results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 12 : 884 888, 1997
3. Gotch FA, Sargent JA : A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28 : 526 534, 1985
4. Eknoyan G, Beck GJ, Cheung AK, et al. : Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347 : 2010 2019, 2002
5. Paniagua R, Amato D, Vonesh E, et al. : Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13 : 1307 1320, 2002
6. Eloot S, Van Biesen W, Dhondt A, Van de Wynkele H, Glorieux G, Verdonck P, Vanholder R : The impact on the removal of uremic retention solutes of modifying only hemodialysis duration. Kidney Int 73 : 765 770, 2008
7. Lowrie EG, Li Z, Ofsthun N, Lazarus JM : Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int 62 : 1891 1897, 2002
8. Vanholder R, Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J : A bench to bedside view of uremic toxins. J Am Soc Nephrol 19 : 863 870, 2008
9. Delmez JA, Yan G, Bailey J, et al. : Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study. Am J Kidney Dis 47 : 131 138, 2006
10. Krane V, Krieter DH, Olschewski M, et al. : Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am J Kidney Dis 49 : 267 275, 2007
11. Canaud B, Bragg-Gresham JL, Marshall MR, et al. : Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 69 : 2087 2093, 2006
12. Leypoldt JK, Cheung AK, Deeter RB : Rebound kinetics of beta2-microglobulin after hemodialysis. Kidney Int 56 : 1571 1577, 1999
13. Eloot S, Torremans A, De Smet R, et al. : Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Kidney Int 67 : 1566 1575, 2005
14. Eloot S, Torremans A, De Smet R, et al. : Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes. Am J Kidney Dis 50 : 279 288, 2007
15. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W : A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 11 : 2344 2350, 2000
16. Cheung AK, Rocco MV, Yan G, et al. : Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 17 : 546 555, 2006
17. Cheung AK, Greene T, Leypoldt JK, et al. : Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol 3 : 69 77, 2008
18. Wilson AM, Kimura E, Harada RK, et al. : Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation 116 : 1396 1403, 2007
19. Saijo Y, Utsugi M, Yoshioka E, et al. : Relationship of beta2-microglobulin to arterial stiffness in Japanese subjects. Hypertens Res 28 : 505 511, 2005
20. Revillard JP, Vincent C, Clot J, Sany J : beta 2-Microglobulin and beta 2-microglobulin-binding proteins in inflammatory diseases. Eur J Rheumatol Inflamm 5 : 398 405, 1982
21. Locatelli F, Hannedouche T, Jacobson S, et al. : The effect of membrane permeability on ESRD: design of a prospective randomised multicentre trial. J Nephrol 12 : 85 88, 1999
22. Vanholder R, De Smet R, Glorieux G, et al. : Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63 : 1934 1943, 2003
23. Jankowski V, Karadogan S, Vanholder R, et al. : Paracrine stimulation of vascular smooth muscle proliferation by diadenosine polyphosphates released from proximal tubule epithelial cells. Kidney Int 71 : 994 1000, 2007
24. Jankowski V, Tolle M, Vanholder R, et al. : Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor. Nat Med 11 : 223 227, 2005
25. Jankowski J, Schluter H, Henning L, et al. : The AN69 hemofiltration membrane has a decreasing effect on the intracellular diadenosine pentaphosphate concentration of platelets. Kidney Blood Press Res 26 : 50 54, 2003
26. Vanholder R, Glorieux G, Lameire N : New insights in uremic toxicity. Contrib Nephrol 149 : 315 324, 2005
27. Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y : Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 69 : 1081 1087, 2006
28. Lesaffer G, De Smet R, D'Heuvaert T, et al. : Comparative kinetics of the uremic toxin p-cresol versus creatinine in rats with and without renal failure. Kidney Int 64 : 1365 1373, 2003